Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	48.88	94.17	231.9	272.35	306.02
Short-Term Investments	301.61	295.22	234.18	125.98	0
Cash & Cash Equivalents	350.49	389.39	466.08	398.33	306.02
Cash Growth	-9.99%	-16.45%	17.01%	30.16%	143.15%
Receivables	24.09	13.48	15.41	0	0.37
Inventory	39.71	24.75	19.33	13.93	0
Other Current Assets	10.52	14.91	12.51	7.17	8.75
Total Current Assets	424.8	442.54	513.32	419.43	315.14
Property, Plant & Equipment	116.57	8.56	9.8	10.28	0.09
Long-Term Investments	0.2	0	0	24.38	0
Goodwill and Intangibles	4.98	6.43	8.4	9.33	8.86
Other Long-Term Assets	1.52	13.34	11.84	0.25	0.21
Total Long-Term Assets	123.26	28.32	30.04	44.23	9.16
Total Assets	548.06	470.86	543.37	463.66	324.3
Accounts Payable	54.39	39.99	34.95	24.8	11.18
Deferred Revenue	4.81	3.15	0.19	0	0
Current Debt	15.6	0.94	1.06	0.79	0
Other Current Liabilities	2.39	2.03	4.45	6.41	0.12
Total Current Liabilities	77.19	46.11	40.65	32	11.3
Long-Term Debt	82.01	7.15	7.68	7.62	0
Other Long-Term Liabilities	10.91	12.17	15.95	16.3	14.41
Total Long-Term Liabilities	92.92	19.32	23.63	23.91	14.41
Total Liabilities	170.11	65.43	64.28	55.91	25.7
Total Debt	97.61	8.09	8.74	8.41	0
Debt Growth	1106.81%	-7.45%	3.95%	-	-
Retained Earnings	-942.32	-864.3	-756.12	-575.16	-472.48
Comprehensive Income	-0.73	-1.06	-0.85	-0.81	-0.81
Shareholders' Equity	377.95	405.44	479.09	407.75	298.6
Net Cash / Debt	252.88	381.3	457.34	389.92	306.02
Net Cash / Debt Growth	-33.68%	-16.63%	17.29%	27.42%	143.15%
Net Cash Per Share	1.77	2.69	3.54	3.29	3.29
Working Capital	347.61	396.43	472.68	387.43	303.84
Book Value Per Share	2.64	2.86	3.70	3.44	3.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).